camptothecin has been researched along with carbonates in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Ding, J; He, X; Jiang, X; Lu, W; Zhang, X | 1 |
| Chen, Y; Gou, M; Kang, T; Li, Y; Wu, Y; Zhu, J | 1 |
| Chen, Y; Pan, J; Qing, C; Sun, Y; Tian, Y; Zhang, Y; Zhou, H; Zhu, Q | 1 |
3 other study(ies) available for camptothecin and carbonates
| Article | Year |
|---|---|
Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins.
Topics: Animals; Antineoplastic Agents; Biological Availability; Camptothecin; Carbonates; Cell Division; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Drug Stability; Humans; Lactones; Mice; Prodrugs; Time Factors | 2004 |
Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbonates; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esters; Fatty Acids, Unsaturated; Humans; Hydrophobic and Hydrophilic Interactions; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Molecular Structure; Nanomedicine; Neoplasms, Experimental; Particle Size; Prodrugs; Structure-Activity Relationship; Surface Properties | 2018 |
9-Nitro-20(S)-carbonate-camptothecin (NCP4), a novel prodrug of 9-nitrocamptothecin (9-NC), exhibits potent chemotherapeutic efficacy and improved safety against hepatocarcinoma.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carbonates; Carcinoma, Hepatocellular; Humans; Lactones; Liver Neoplasms; Mice; Prodrugs | 2022 |